These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33836954)

  • 21. Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer).
    Lesueur P; Lequesne J; Barraux V; Kao W; Geffrelot J; Grellard JM; Habrand JL; Emery E; Marie B; Thariat J; Stefan D
    Radiat Oncol; 2018 Jul; 13(1):138. PubMed ID: 30055640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO.
    Scoccianti S; Olmetto E; Pinzi V; Osti MF; Di Franco R; Caini S; Anselmo P; Matteucci P; Franceschini D; Mantovani C; Beltramo G; Pasqualetti F; Bruni A; Tini P; Giudice E; Ciammella P; Merlotti A; Pedretti S; Trignani M; Krengli M; Giaj-Levra N; Desideri I; Pecchioli G; Muto P; Maranzano E; Fariselli L; Navarria P; Ricardi U; Scotti V; Livi L
    Neuro Oncol; 2021 Oct; 23(10):1750-1764. PubMed ID: 34050669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical bed stereotactic radiotherapy of brain metastases: Clinical outcome and predictors of local and distant brain failure.
    Mousli A; Bihin B; Gustin T; Koerts G; Mouchamps M; Daisne JF
    Cancer Radiother; 2020 Jul; 24(4):298-305. PubMed ID: 32173270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of stereotactic radiotherapy in addition to immunotherapy in the management of melanoma brain metastases: results of a systematic review.
    Lancellotta V; Del Regno L; Di Stefani A; Fionda B; Marazzi F; Rossi E; Balducci M; Pampena R; Morganti AG; Mangoni M; Lebbe C; Garbe C; Longo C; Schinzari G; Tagliaferri L; Peris K
    Radiol Med; 2022 Jul; 127(7):773-783. PubMed ID: 35606609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concurrent Radiosurgery and Immune Checkpoint Inhibition: Improving Regional Intracranial Control for Patients With Metastatic Melanoma.
    Murphy B; Walker J; Bassale S; Monaco D; Jaboin J; Ciporen J; Taylor M; Dai Kubicky C
    Am J Clin Oncol; 2019 Mar; 42(3):253-257. PubMed ID: 30557166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhomogeneous tumor dose distribution provides better local control than homogeneous distribution in stereotactic radiotherapy for brain metastases.
    Lucia F; Key S; Dissaux G; Goasduff G; Lucia AS; Ollivier L; Pradier O; Schick U
    Radiother Oncol; 2019 Jan; 130():132-138. PubMed ID: 30017105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis.
    Foster CC; Sher DJ; Rusthoven CG; Verma V; Spiotto MT; Weichselbaum RR; Koshy M
    Radiat Oncol; 2019 Jan; 14(1):18. PubMed ID: 30691492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response assessment and outcome of combining immunotherapy and radiosurgery for brain metastasis from malignant melanoma.
    Le Rhun E; Wolpert F; Fialek M; Devos P; Andratschke N; Reyns N; Regli L; Dummer R; Mortier L; Weller M
    ESMO Open; 2020 Aug; 5(4):. PubMed ID: 32747372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Local progression and pseudo progression after single fraction or fractionated stereotactic radiotherapy for large brain metastases. A single centre study.
    Wiggenraad R; Verbeek-de Kanter A; Mast M; Molenaar R; Kal HB; Lycklama à Nijeholt G; Vecht C; Struikmans H
    Strahlenther Onkol; 2012 Aug; 188(8):696-701. PubMed ID: 22722818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiinstitutional prospective observational study of stereotactic radiosurgery for patients with multiple brain metastases from non-small cell lung cancer (JLGK0901 study-NSCLC).
    Shuto T; Akabane A; Yamamoto M; Serizawa T; Higuchi Y; Sato Y; Kawagishi J; Yamanaka K; Jokura H; Yomo S; Nagano O; Aoyama H
    J Neurosurg; 2018 Dec; 129(Suppl1):86-94. PubMed ID: 30544291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
    Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
    J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors in patients with non-small cell lung carcinoma and brain metastases: a Malaysian perspective.
    Tang WH; Alip A; Saad M; Phua VC; Chandran H; Tan YH; Tan YY; Kua VF; Wahid MI; Tho LM
    Asian Pac J Cancer Prev; 2015; 16(5):1901-6. PubMed ID: 25773842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain metastasis formation and irradiation by stereotactic radiation therapy combined with immunotherapy: A systematic review.
    Pin Y; Paix A; Todeschi J; Antoni D; Proust F; Noël G
    Crit Rev Oncol Hematol; 2020 May; 149():102923. PubMed ID: 32199131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunotherapy and Symptomatic Radiation Necrosis in Patients With Brain Metastases Treated With Stereotactic Radiation.
    Martin AM; Cagney DN; Catalano PJ; Alexander BM; Redig AJ; Schoenfeld JD; Aizer AA
    JAMA Oncol; 2018 Aug; 4(8):1123-1124. PubMed ID: 29327059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can upfront systemic chemotherapy replace stereotactic radiosurgery or whole brain radiotherapy in the treatment of non-small cell lung cancer patients with asymptomatic brain metastases?
    Kim KH; Lee J; Lee JI; Nam DH; Kong DS; Ahn YC; Park HC; Kwon OJ; Kim H; Chang MH; Yi SY; Ji SH; Park YH; Ahn JS; Park K; Ahn MJ
    Lung Cancer; 2010 May; 68(2):258-63. PubMed ID: 19592127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multidose stereotactic radiosurgery (9 Gy × 3) of the postoperative resection cavity for treatment of large brain metastases.
    Minniti G; Esposito V; Clarke E; Scaringi C; Lanzetta G; Salvati M; Raco A; Bozzao A; Maurizi Enrici R
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):623-9. PubMed ID: 23683828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereotactic radiosurgery combined with anti-PD1 for the management of melanoma brain metastases: A retrospective study of safety and efficacy.
    Carron R; Gaudy-Marqueste C; Amatore F; Padovani L; Malissen N; Balossier A; Loundou A; Bonnet N; Muracciole X; Régis JM; Grob JJ
    Eur J Cancer; 2020 Aug; 135():52-61. PubMed ID: 32535348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complete intracranial response to talimogene laherparepvec (T-Vec), pembrolizumab and whole brain radiotherapy in a patient with melanoma brain metastases refractory to dual checkpoint-inhibition.
    Blake Z; Marks DK; Gartrell RD; Hart T; Horton P; Cheng SK; Taback B; Horst BA; Saenger YM
    J Immunother Cancer; 2018 Apr; 6(1):25. PubMed ID: 29622046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiotherapy and immunotherapy: Can this combination change the prognosis of patients with melanoma brain metastases?
    Franceschini D; Franzese C; Navarria P; Ascolese AM; De Rose F; Del Vecchio M; Santoro A; Scorsetti M
    Cancer Treat Rev; 2016 Nov; 50():1-8. PubMed ID: 27566962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.